CTOs on the Move

Journey Colab

www.journeycolab.com

 
We are pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. We plan to build a portfolio of plant-identical compounds. Our first compound in development is mescaline.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Journey Colab raised $15.7M on 11/01/2021

Similar Companies

YourPath

YourPath is a healthcare provider that offers medication-assisted treatment and comprehensive assessments for individuals affected by substance use disorders.

Wimbledon Health Partners

Wimbledon Health Partners formed in 2013 to meet the need for on-site diagnostic testing at physicians’ offices. The industry leader, Wimbledon Health Partners provides physicians with state-of-the-art, in-office testing to detect circulatory conditions using vascular ultrasound and electro- and echocardiography. Nerve conduction velocity testing is also used to support diagnosis of problems related to the nervous and muscular systems. Wimbledon Athletics, the newest division of Wimbledon Health Partners, is pioneering the way for high schools, colleges and universities to test students for unsuspected heart abnormalities to help minimize sudden cardiac death among young athletes.

Med Help International

Med Help International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Melbourne, FL. To find more information about Med Help International, please visit www.medhelp.org

Exthera Medical

Exthera Medical is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Holmusk

Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore with offices in North Carolina, New York City, London, Malaysia and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk`s vision is to build the world`s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools. Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.